Skip to main content
SpringerLink
Log in

PTH and PTHrP Effects on the Skeleton

  • Published:
Reviews in Endocrine and Metabolic Disorders Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Habener JF, Rosenblatt M, Potts JT, Jr. Parathyroid hormone: biochemical aspects of biosynthesis, secretion, action, and metabolism. Physiol Rev 1984;64:985-1053.

    Google Scholar 

  2. Fitzpatrick LA, Coleman DT, Bilezikian JP. Disorders of Bone and Mineral Metabolism. New York: Raven Press, 1992;123-148.

    Google Scholar 

  3. Karaplis AC, Vautour L. Parathyroid hormone-related peptide and the parathyroid hormone/parathyroid hormone-related peptide receptor in skeletal development. Curr Opin Nephrol Hypertens 1997;6:308-313.

    Google Scholar 

  4. Potts JT, Jr, Kronenberg HM, Rosenblatt M. Parathyroid hormone: chemistry, biosynthesis, and mode of action. Adv Protein Chem 1982;35:323-396.

    Google Scholar 

  5. Juppner H, Abou-Samra AB, Freeman M, Kong XF, Schipani E, Richards J, Kolakowski LF, Jr, Hock J, Potts JT, Jr, Kronenberg HM, Segre GV. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 1991;254:1024-1026.

    Google Scholar 

  6. Boyce BF, Yoneda T, Guise TA. Factors regulating the growth of metastatic cancer in bone. Endocr Relat Cancer 1999;6:333-347.

    Google Scholar 

  7. Usdin TB, Gruber C, Bonner TI. Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem 1995;270:15455-15458.

    Google Scholar 

  8. Usdin TB, Bonner TI, Harta G, Mezey E. Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat. Endocrinology 1996;137:4285-4297.

    Google Scholar 

  9. Usdin TB, Hilton J, Vertesi T, Harta G, Segre G, Mezey E. Distribution of the parathyroid hormone 2 receptor in rat: immunolocalization reveals expression by several endocrine cells. Endocrinology 1999;140:3363-3371.

    Google Scholar 

  10. Clark JA, Bonner TI, Kim AS, Usdin TB. Multiple regions of ligand discrimination revealed by analysis of chimeric parathyroid hormone 2 (PTH2) and PTH/PTH-related peptide (PTHrP) receptors. Mol Endocrinol 1998;12:193-206.

    Google Scholar 

  11. Usdin TB, Hoare SR, Wang T, Mezey E, Kowalak JA. TIP39: a new neuropeptide and PTH2-receptor agonist from hypothalamus. Nat Neurosci 1999;2:941-943.

    Google Scholar 

  12. Inomata N, Akiyama M, Kubota N, Juppner H. Characterization of a novel parathyroid hormone (PTH) receptor with specificity for the carboxyl-terminal region of PTH-(1-84). Endocrinology 1995; 136:4732-4740.

    Google Scholar 

  13. Takasu H, Baba H, Inomata N, Uchiyama Y, Kubota N, Kumaki K, Matsumoto A, Nakajima K, Kimura T, Sakakibara S, Fujita T, Chihara K, Nagai I. The 69-84 amino acid region of the parathyroid hormone molecule is essential for the interaction of the hormone with the binding sites with carboxyl-terminal specificity. Endocrinology 1996;137:5537-5543.

    Google Scholar 

  14. Schluter KD, Hellstern H, Wingender E, Mayer H. The central part of parathyroid hormone stimulates thymidine incorporation of chondrocytes. J Biol Chem 1989;264:11087-11092.

    Google Scholar 

  15. Erdmann S, Muller W, Bahrami S, Vornehm SI, Mayer H, Bruckner P, von der Mark K, Burkhardt H. Differential effects of parathyroid hormone fragments on collagen gene expression in chondrocytes. J Cell Biol 1996;135:1179-1191.

    Google Scholar 

  16. Erdmann S, Burkhardt H, von der Mark K, Muller W. Mapping of a carboxyl-terminal active site of parathyroid hormone by calciumimaging. Cell Calcium 1998;23:413-421.

    Google Scholar 

  17. Parkinson DB, Thakker RV. A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism. Nat Genet 1992;1:149-152.

    Google Scholar 

  18. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM, Mulligan RC. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 1994;8:277-289.

    Google Scholar 

  19. Amizuka N, Warshawsky H, Henderson JE, Goltzman D, Karaplis AC. Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J Cell Biol 1994;126:1611-1623.

    Google Scholar 

  20. Amizuka N, Henderson JE, Hoshi K, Warshawsky H, Ozawa H, Goltzman D, Karaplis AC. Programmed cell death of chondrocytes and aberrant chondrogenesis in mice homozygous for parathyroid hormone-related peptide gene deletion. Endocrinology 1996; 137:5055-5067.

    Google Scholar 

  21. Schipani E, Kruse K, Juppner H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 1995;268:98-100.

    Google Scholar 

  22. Schipani E, Langman CB, Parfitt AM, Jensen GS, Kikuchi S, Kooh SW, Cole WG, Juppner H. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. N Engl J Med 1996; 335:708-714.

    Google Scholar 

  23. Schipani E, Langman C, Hunzelman J, Le Merrer M, Loke KY, Dillon MJ, Silve C, Juppner H. A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia. J Clin Endocrinol Metab 1999;84: 3052-3057.

    Google Scholar 

  24. Schipani E, Lanske B, Hunzelman J, Luz A, Kovacs CS, Lee K, Pirro A, Kronenberg HM, Juppner H. Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. Proc Natl Acad Sci USA 1997;94:13689-13694.

    Google Scholar 

  25. Weir EC, Philbrick WM, Amling M, Neff LA, Baron R, Broadus AE. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci USA 1996;93: 10240-10245.

    Google Scholar 

  26. Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A, Karperien M, Defize LHK, Ho C, Mulligan RC, Abou-Samra AB, Juppner H, Segre GV, Kronenberg HM. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 1996;273:663-666.

    Google Scholar 

  27. Jobert AS, Zhang P, Couvineau A, Bonaventure J, Roume J, Le Merrer M, Silve C. Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest 1998;102:34-40.

    Google Scholar 

  28. Zhang P, Jobert AS, Couvineau A, Silve C. A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia. J Clin Endocrinol Metab 1998;83:3365-3368.

    Google Scholar 

  29. Karaplis AC, He B, Nguyen MT, Young ID, Semeraro D, Ozawa H, Amizuka N. Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia. Endocrinology 1998;139:5255-5258.

    Google Scholar 

  30. Karperien M, van der Harten HJ, van Schooten R, Farih-Sips H, den Hollander NS, Kneppers SL, Nijweide P, Papapoulos SE, Lowik CW. A frame-shift mutation in the type I parathyroid hormone (PTH)/PTH-related peptide receptor causing Blomstrand lethal osteochondrodysplasia. J Clin Endocrinol Metab 1999;84:3713-3720.

    Google Scholar 

  31. Lanske B, Amling M, Neff L, Guiducci J, Baron R, Kronenberg HM. Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J Clin Invest 1999;104:399-407.

    Google Scholar 

  32. Henderson JE, Amizuka N, Warshawsky H, Biasotto D, Lanske BM, Goltzman D, Karaplis AC. Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death. Mol Cell Biol 1995;15:4064-4075.

    Google Scholar 

  33. Massfelder T, Dann P, Wu TL, Vasavada R, Helwig JJ, Stewart AF. Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting. Proc Natl Acad Sci USA 1997;94:13630-13635.

    Google Scholar 

  34. </del>Lam MH, Briggs LJ, Hu W, Martin TJ, Gillespie MT, Jans DA. Importin beta recognizes parathyroid hormone-related protein with high affinity and mediates its nuclear import in the absence of importin alpha. J Biol Chem 1999;274:7391-7398.

    Google Scholar 

  35. Rouleau MF, Warshawsky H, Goltzman D. Parathyroid hormone binding in vivo to renal, hepatic, and skeletal tissues of the rat using a radioautographic approach. Endocrinology 1986;118:919-931.

    Google Scholar 

  36. Lee K, Deeds JD, Chiba S, Un-No M, Bond AT, Segre GV. Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids. Endocrinology 1994;134:441-450.

    Google Scholar 

  37. Fermor B, Skerry TM. PTH/PTHrP receptor expression on osteoblasts and osteocytes but not resorbing bone surfaces in growing rats. J Bone Miner Res 1995;10:1935-1943.

    Google Scholar 

  38. Celic S, Chilco PJ, Zajac JD, Martin TJ, Findlay DM. A type I collagen substrate increases PTH/PTHrP receptor mRNA expression and suppresses PTHrP mRNA expression in UMR106-06 osteoblast-like cells. J Endocrinol 1996;150:299-308.

    Google Scholar 

  39. Owen M, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 1988;136:42-60.

    Google Scholar 

  40. Roodman GD. Cell biology of the osteoclast. Exp Hematol 1999;27:1229-1241.

    Google Scholar 

  41. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Goto M, Mochizuki SI, Tsuda E, Morinaga T, Udagawa N, Takahashi N, Suda T, Higashio K. A novel molecular mechanism modulating osteoclast differentiation and function. Bone 1999;25:109-113.

    Google Scholar 

  42. Lee SK, Lorenzo JA. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology 1999;140:3552-3561.

    Google Scholar 

  43. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997;89:747-754.

    Google Scholar 

  44. Porte D, Tuckermann J, Becker M, Baumann B, Teurich S, Higgins T, Owen MJ, Schorpp-Kistner M, Angel P. Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone. Oncogene 1999;18:667-678.

    Google Scholar 

  45. Morony S, Capparelli C, Lee R, Shimamoto G, Boone T, Lacey DL, Dunstan CR. A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNFalpha, PTH, PTHrP, and 1, 25(OH)2D3. J Bone Miner Res 1999;14:1478-1485.

    Google Scholar 

  46. Bauer W, Aub JC, Albright F. Studies of calcium phosphorus metabolisms: study of bone trabeculae as ready available reserve supply of calcium. J Exp Med 1929;49:145-162.

    Google Scholar 

  47. Selye H. On the stimulation of new bone-formation with parathyroid extract and irradiated ergosterol. Endocrinology 1932;16:547-558.

    Google Scholar 

  48. Hollnagel A, Ahrens M, Gross G. Parathyroid hormone enhances early and suppresses late stages of osteogenic and chondrogenic development in a BMP-dependent mesenchymal differentiation system (C3H10T1/2). J Bone Miner Res 1997;12:1993-2004.

    Google Scholar 

  49. Liang JD, Hock JM, Sandusky GE, Santerre RF, Onyia JE. Immunohistochemical localization of selected early response genes expressed in trabecular bone of young rats given hPTH 1-34. Calcif Tissue Int 1999;65:369-373.

    Google Scholar 

  50. McCauley LK, Koh AJ, Beecher CA, Rosol TJ. Proto-oncogene cfos is transcriptionally regulated by parathyroid hormone (PTH) and PTH-related protein in a cyclic adenosine monophosphatedependent manner in osteoblastic cells. Endocrinology 1997;138:5427-5433.

    Google Scholar 

  51. Tyson DR, Swarthout JT, Partridge NC. Increased osteoblastic c-fos expression by parathyroid hormone requires protein kinase A phosphorylation of the cyclic adenosine 30,50-monophosphate response element-binding protein at serine 133. Endocrinology 1999;140:1255-1261.

    Google Scholar 

  52. Takeda N, Tsuboyama T, Kasai R, Takahashi K, Shimizu M, Nakamura T, Higuchi K, Hosokawa M. Expression of the c-fos gene induced by parathyroid hormone in the bones of SAMP6 mice, a murine model for senile osteoporosis. Mech Ageing Dev 1999;108:87-97.

    Google Scholar 

  53. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 1999;104:439-446.

    Google Scholar 

  54. Jilka RL, Weinstein RS, Takahashi K, Parfitt AM, Manolagas SC. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest 1996;97:1732-1740.

    Google Scholar 

  55. Cosman F, Lindsay R. Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence. Calcif Tissue Int 1998;62:475-480.

    Google Scholar 

  56. Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R. Anabolic actions of parathyroid hormone on bone. Endocr Rev 1993;14:690-709.

    Google Scholar 

  57. Hock JM. Stemming bone loss by suppressing apoptosis. J Clin Invest 1999;104:371-373.

    Google Scholar 

  58. Lee K, Deeds JD, Segre GV. Expression of parathyroid hormonerelated peptide and its receptor messenger ribonucleic acids during fetal development of rats. Endocrinology 1995;136:453-463.

    Google Scholar 

  59. Suda N, Gillespie MT, Traianedes K, Zhou H, Ho PW, Hards DK, Allan EH, Martin TJ, Moseley JM. Expression of parathyroid hormone-related protein in cells of osteoblast lineage. J Cell Physiol 1996;166:94-104.

    Google Scholar 

  60. Amizuka N, Karaplis AC, Henderson JE, Warshawsky H, Lipman ML, Matsuki Y, Ejiri S, Tanaka M, Izumi N, Ozawa H, Goltzman D. Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Dev Biol 1996;175:166-176.

    Google Scholar 

  61. Chan G, Goltzman D, Karaplis AC. PTHrP inhibits adipogenesis by downregulating PPARg activity via MAP kinase signalling. J Bone Miner Res 1999;14, Suppl 1:S136.

    Google Scholar 

  62. Canalis E, McCarthy TL, Centerlla M. Differential effects of continuous and transient treatment with parathyroid hormone related peptide (PTHrp) on bone collagen synthesis. Endocrinology 1990;126:1806-1812.

    Google Scholar 

  63. Pollock JH, Blaha MJ, Lavish SA, Stevenson S, Greenfield EM. In vivo demonstration that parathyroid hormone and parathyroid hormone-related protein stimulate expression by osteoblasts of interleukin-6 and leukemia inhibitory factor. J Bone Miner Res 1996;11:754-759.

    Google Scholar 

  64. Duncan EL, Brown MA, Sinsheimer J, Bell J, Carr AJ, Wordsworth BP, Wass JA. Suggestive linkage of the parathyroid receptor type 1 to osteoporosis. J Bone Miner Res 1999;14:1993-1999.

    Google Scholar 

  65. Reeve J. PTH: a future role in the management of osteoporosis?. J Bone Miner Res 1996;11:440-445.

    Google Scholar 

  66. Finkelstein JS, Klibanski A, Schaefer EH, Hornstein MD, Schiff I, Neer RM. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med 1994;331:1618-1623.

    Google Scholar 

  67. Finkelstein JS, Klibanski A, Arnold AL, Toth TL, Hornstein MD, Neer RM. Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial. JAMA 1998;280:1067-1073.

    Google Scholar 

  68. Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D, Cosman F. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 1997;350:550-555.

    Google Scholar 

  69. Lane NE, Sanchez S, Modin GW, Genant HK, ini E, Arnaud CD. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest 1998;102:1627-1633.

    Google Scholar 

  70. Hock JM, Fonseca J, Gunness-Hey M, Kemp BE, Martin TJ. Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34 on bone in rats. Endocrinology 1989;125:2022-2027.

    Google Scholar 

  71. Fraher LJ, Klein K, Marier R, Freeman D, Hendy GN, Goltzman D, Hodsman AB. Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans. J Clin Endocrinol Metab 1995;80:60-64.

    Google Scholar 

  72. Everhart-Caye M, Inzucchi SE, Guinness-Henry J, Mitnick MA, Stewart AF. Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH(1-34) in humans. J Clin Endocrinol Metab 1996;81:199-208.

    Google Scholar 

  73. Plotkin H, Gundberg C, Mitnick M, Stewart AF. Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis. J Clin Endocrinol Metab 1998;83:2786-2791.

    Google Scholar 

  74. Pellegrini M, Bisello A, Rosenblatt M, Chorev M, Mierke DF. Conformational studies of RS-66271, an analog of parathyroid hormone-related protein with pronounced bone anabolic activity. J Med Chem 1997;40:3025-3031.

    Google Scholar 

  75. Vickery BH, Avnur Z, Cheng Y, Chiou SS, Leaffer D, Caulfield JP, Kimmel DB, Ho T, Krstenansky JL. RS-66271, a C-terminally substituted analog of human parathyroid hormone-related protein (1-34), increases trabecular and cortical bone in ovariectomized, osteopenic rats. J Bone Miner Res 1996;11:1943-1951.

    Google Scholar 

  76. Leaffer D, Sweeney M, Kellerman LA, Avnur Z, Krstenansky JL, Vickery BH, Caulfield JP. Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH-(1-34). Endocrinology 1995;136:3624-3631.

    Google Scholar 

  77. Stewart AF. PTHrP(1-36) as a skeletal anabolic agent for the treatment of osteoporosis. Bone 1996;19:303-306.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, and Lady Davis Institute for Medical Research and McGill University, Montre´al, Canada

    Andrew C. Karaplis

  2. Calcium Research Laboratory, Department of Medicine, Royal Victoria Hospital and McGill University, Montre´al, Canada

    David Goltzman

Authors
  1. Andrew C. Karaplis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Goltzman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karaplis, A.C., Goltzman, D. PTH and PTHrP Effects on the Skeleton. Rev Endocr Metab Disord 1, 331–341 (2000). https://doi.org/10.1023/A:1026526703898

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026526703898

Search

Navigation